Glück Conviction Score™ ⓘ
GLUE
Monte Rosa Therapeutics, Inc.
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
59,2
44 neu, 83 erhöht, 370,8M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 18.59 | -1.9 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 15.58 | +17.1 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 17.94 | EMA50: 18.24 | |
| MACD-Histogramm | Bärisch | 10 % | -0.104 | Bearisch | |
| RSI(14) | Neutral | 10 % | 51.1 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 50.1 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 18.5 | +DI: 23.3 / −DI: 17.1 | |
| Z-Score(60) | Neutral | 5 % | 0.08 | In Range | |
| 52W-Position | Neutral | 5 % | 66.5 % | Hoch 25.31 / Tief 4.19 | |
| Bollinger(20,2σ) | Neutral | 5 % | 53.7 % | Upper 20.17 / Mid 18.09 / Lower 16.01 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0329 | R²=0.14 / annualisiert +45.7 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -4.998 | 19,41 | -97.021,18 | -108,1% | |
| 2026-06-01 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -468 | 19,73 | -9.231,86 | -10,3% | |
| 2026-05-29 | Townson Sharon | Officer, Chief Scientific Officer | Open Market Sale | -6.000 | 19,87 | -119.220,00 | -132,8% | |
| 2026-05-27 | Champoux Jennifer | Officer, Chief Operating Officer | Open Market Sale | -2.175 | 20,00 | -43.500,00 | -48,5% | |
| 2026-05-22 | Champoux Jennifer | Officer, Chief Operating Officer | Open Market Sale | -2.176 | 19,00 | -41.344,00 | -46,1% | |
| 2026-05-21 | Manning Anthony M. | Director | Open Market Sale | -10.000 | 18,01 | -180.100,00 | -200,7% | |
| 2026-05-01 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -5.467 | 18,92 | -103.446,57 | -115,3% | |
| 2026-04-14 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -8.000 | 17,64 | -141.124,80 | -157,2% | |
| 2026-04-09 | Nickson Philip | Officer, Chief Business & Legal Officer | Open Market Sale | -5.845 | 17,69 | -103.412,66 | -115,2% | |
| 2026-03-04 | Dunn Edmund | Officer, Principal Accounting Officer | Open Market Sale | -139 | 17,96 | -2.496,44 | -2,8% | |
| 2026-03-02 | Dunn Edmund | Officer, Principal Accounting Officer | Open Market Sale | -536 | 17,50 | -9.380,00 | -10,5% | |
| 2026-03-02 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -5.466 | 17,92 | -97.974,22 | -109,2% | |
| 2026-02-27 | Dunn Edmund | Officer, Principal Accounting Officer | Open Market Sale | -25.164 | 18,10 | -455.506,15 | -507,5% | |
| 2026-02-23 | Janku Filip | Officer, Chief Medical Officer | Open Market Sale | -9.189 | 19,50 | -179.160,69 | -199,6% | |
| 2026-01-07 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -3.707 | 23,24 | -86.158,84 | -96,0% | |
| 2026-01-07 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -1.450 | 23,88 | -34.620,49 | -38,6% | |
| 2026-01-07 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -309 | 24,57 | -7.593,24 | -8,5% | |
| 2026-01-05 | Nickson Philip | Officer, Chief Business & Legal Officer | Open Market Sale | -3.155 | 15,17 | -47.861,35 | -53,3% | |
| 2026-01-05 | Warmuth Markus | Director, Officer, President & CEO | Open Market Sale | -10.135 | 15,17 | -153.747,95 | -171,3% | |
| 2026-01-05 | Townson Sharon | Officer, Chief Scientific Officer | Open Market Sale | -3.155 | 15,17 | -47.861,35 | -53,3% | |
| 2026-01-05 | Janku Filip | Officer, Chief Medical Officer | Open Market Sale | -3.155 | 15,17 | -47.861,35 | -53,3% | |
| 2026-01-05 | Champoux Jennifer | Officer, Chief Operating Officer | Open Market Sale | -2.629 | 15,17 | -39.881,93 | -44,4% | |
| 2026-01-05 | Dunn Edmund | Officer, Principal Accounting Officer | Open Market Sale | -1.039 | 15,17 | -15.761,63 | -17,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC | 7.692.298 | 7.692.298 | 0 | 126.538.302 | Unverändert | 0,0% | |
| BlackRock, Inc. | 5.637.684 | 4.181.161 | 1.456.523 | 92.739.901 | Aufgestockt | +34,8% | |
| TCG Crossover Management, LLC | 4.622.151 | 4.622.151 | 0 | 76.034.384 | Unverändert | 0,0% | |
| BVF INC/IL | 4.460.886 | 3.835.886 | 625.000 | 73.381.575 | Aufgestockt | +16,3% | |
| BAKER BROS. ADVISORS LP | 4.345.736 | 4.345.736 | 0 | 71.487.357 | Unverändert | 0,0% | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.226.809 | 3.360.000 | 866.809 | 69.531.008 | Aufgestockt | +25,8% | |
| Vestal Point Capital, LP | 3.603.465 | 775.000 | 2.828.465 | 59.276.999 | Aufgestockt | +365,0% | |
| STATE STREET CORP | 3.353.980 | 2.107.480 | 1.246.500 | 55.172.971 | Aufgestockt | +59,1% | |
| BRAIDWELL LP | 3.206.574 | 948.316 | 2.258.258 | 52.748.142 | Aufgestockt | +238,1% | |
| Versant Venture Management, LLC | 3.180.780 | 4.382.687 | -1.201.907 | 52.323.831 | Reduziert | -27,4% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.100.245 | 0 | 3.100.245 | 50.999.030 | Neu | +100,0% | |
| VANGUARD GROUP INC | 3.246.500 | 0 | 3.246.500 | 50.905.120 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 2.809.647 | 1.329.619 | 1.480.028 | 46.218.693 | Aufgestockt | +111,3% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.002.040 | 1.029.066 | 972.974 | 32.933.558 | Aufgestockt | +94,5% | |
| Aisling Capital Management LP | 1.555.664 | 1.472.331 | 83.333 | 25.590.673 | Aufgestockt | +5,7% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.540.812 | 1.204.844 | 335.968 | 25.352.784 | Aufgestockt | +27,9% | |
| MARSHALL WACE, LLP | 1.433.152 | 398.890 | 1.034.262 | 23.575.351 | Aufgestockt | +259,3% | |
| Bellevue Group AG | 1.250.000 | 0 | 1.250.000 | 20.562.500 | Neu | +100,0% | |
| MPM BioImpact LLC | 1.176.928 | 1.173.376 | 3.552 | 19.360.466 | Aufgestockt | +0,3% | |
| DIMENSIONAL FUND ADVISORS LP | 1.041.372 | 568.367 | 473.005 | 17.124.824 | Aufgestockt | +83,2% | |
| FMR LLC | 1.024.304 | 1.300.096 | -275.792 | 16.849.800 | Reduziert | -21,2% | |
| GOLDMAN SACHS GROUP INC | 1.001.527 | 295.878 | 705.649 | 16.475.119 | Aufgestockt | +238,5% | |
| Frazier Life Sciences Management, L.P. | 1.000.000 | 0 | 1.000.000 | 16.450.000 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 826.624 | 697.034 | 129.590 | 13.597.964 | Aufgestockt | +18,6% | |
| JANUS HENDERSON GROUP PLC | 685.926 | 0 | 685.926 | 11.293.772 | Neu | +100,0% | |
| Alphabet Inc. | 684.275 | 744.948 | -60.673 | 11.256.324 | Reduziert | -8,1% | |
| MORGAN STANLEY | 684.063 | 805.530 | -121.467 | 11.252.836 | Reduziert | -15,1% | |
| AQR CAPITAL MANAGEMENT LLC | 658.483 | 785.057 | -126.574 | 10.832.046 | Reduziert | -16,1% | |
| Nantahala Capital Management, LLC | 651.993 | 57.991 | 594.002 | 10.725.285 | Aufgestockt | +1024,3% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 647.739 | 307.651 | 340.088 | 10.655.307 | Aufgestockt | +110,5% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 546.689 | 448.714 | 97.975 | 8.993.034 | Aufgestockt | +21,8% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 528.698 | 523.377 | 5.321 | 8.697.082 | Aufgestockt | +1,0% | |
| Cormorant Asset Management, LP | 400.000 | 0 | 400.000 | 6.580.000 | Neu | +100,0% | |
| Allspring Global Investments Holdings, LLC | 392.227 | 26.955 | 365.272 | 6.452.134 | Aufgestockt | +1355,1% | |
| BANK OF AMERICA CORP /DE/ | 387.542 | 223.571 | 163.971 | 6.375.066 | Aufgestockt | +73,3% | |
| RENAISSANCE TECHNOLOGIES LLC | 379.100 | 0 | 379.100 | 6.236.195 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 318.118 | 84.463 | 233.655 | 5.233.041 | Aufgestockt | +276,6% | |
| Fisher Asset Management, LLC | 314.862 | 0 | 314.862 | 5.179.479 | Neu | +100,0% | |
| Empowered Funds, LLC | 305.398 | 278.077 | 27.321 | 5.023.797 | Aufgestockt | +9,8% | |
| Nextech Invest, Ltd. | 304.237 | 279.237 | 25.000 | 5.004.699 | Aufgestockt | +9,0% | |
| TD ASSET MANAGEMENT INC | 286.978 | 213.464 | 73.514 | 4.720.788 | Aufgestockt | +34,4% | |
| BALYASNY ASSET MANAGEMENT L.P. | 256.731 | 0 | 256.731 | 4.223.225 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 250.000 | 0 | 250.000 | 4.112.500 | Neu | +100,0% | |
| ADAR1 Capital Management, LLC | 215.752 | 215.752 | 0 | 3.549.120 | Unverändert | 0,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 209.801 | 134.674 | 75.127 | 3.451.226 | Aufgestockt | +55,8% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 200.000 | 200.000 | 0 | 3.290.000 | Unverändert | 0,0% | |
| FRANKLIN RESOURCES INC | 199.722 | 85.231 | 114.491 | 3.285.427 | Aufgestockt | +134,3% | |
| Atom Investors LP | 194.476 | 137.261 | 57.215 | 3.199.130 | Aufgestockt | +41,7% | |
| MILLENNIUM MANAGEMENT LLC | 191.382 | 103.972 | 87.410 | 3.148.234 | Aufgestockt | +84,1% | |
| DIADEMA PARTNERS LP | 187.307 | 62.281 | 125.026 | 3.081.200 | Aufgestockt | +200,7% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7.692.298 | 7.692.298 | 0,0% | 126.538.302 | 9,78 |
| BlackRock, Inc. | 5.637.684 | 4.181.161 | +34,8% | 92.739.901 | 7,17 |
| TCG Crossover Management, LLC | 4.622.151 | 4.622.151 | 0,0% | 76.034.384 | 5,88 |
| BVF INC/IL | 4.460.886 | 3.835.886 | +16,3% | 73.381.575 | 5,67 |
| BAKER BROS. ADVISORS LP | 4.345.736 | 4.345.736 | 0,0% | 71.487.357 | 5,53 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.226.809 | 3.360.000 | +25,8% | 69.531.008 | 5,37 |
| Vestal Point Capital, LP | 3.603.465 | 775.000 | +365,0% | 59.276.999 | 4,58 |
| STATE STREET CORP | 3.353.980 | 2.107.480 | +59,1% | 55.172.971 | 4,26 |
| BRAIDWELL LP | 3.206.574 | 948.316 | +238,1% | 52.748.142 | 4,08 |
| Versant Venture Management, LLC | 3.180.780 | 4.382.687 | -27,4% | 52.323.831 | 4,04 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.100.245 | 0 | +100,0% | 50.999.030 | 3,94 |
| AMERICAN CENTURY COMPANIES INC | 2.809.647 | 1.329.619 | +111,3% | 46.218.693 | 3,57 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.002.040 | 1.029.066 | +94,5% | 32.933.558 | 2,55 |
| Aisling Capital Management LP | 1.555.664 | 1.472.331 | +5,7% | 25.590.673 | 1,98 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.540.812 | 1.204.844 | +27,9% | 25.352.784 | 1,96 |
| MARSHALL WACE, LLP | 1.433.152 | 398.890 | +259,3% | 23.575.351 | 1,82 |
| Bellevue Group AG | 1.250.000 | 0 | +100,0% | 20.562.500 | 1,59 |
| MPM BioImpact LLC | 1.176.928 | 1.173.376 | +0,3% | 19.360.466 | 1,50 |
| DIMENSIONAL FUND ADVISORS LP | 1.041.372 | 568.367 | +83,2% | 17.124.824 | 1,32 |
| FMR LLC | 1.024.304 | 1.300.096 | -21,2% | 16.849.800 | 1,30 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 188 | 90,9 | 1.374 |
| 31.12.2025 | ✓ | 160 | 66,6 | 948 |
| 30.09.2025 | ✓ | 129 | 61,8 | 414 |
| 30.06.2025 | ✓ | 117 | 63,0 | 249 |
| 31.03.2025 | ✓ | 104 | 60,7 | 246 |
| 31.12.2024 | ✓ | 106 | 63,6 | 389 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| TCG Crossover Management, LLC | 4.622.151 | 72.475.328 |
| MPM BioImpact LLC | 1.173.376 | 18.398.536 |
| BRAIDWELL LP | 948.316 | 14.869.595 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 307.651 | 4.823.968 |
| Nextech Invest, Ltd. | 279.237 | 4.378.436 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 200.000 | 3.136.000 |
| J. Goldman & Co LP | 167.291 | 2.623.123 |
| Trexquant Investment LP | 149.712 | 2.347.484 |
| Atom Investors LP | 137.261 | 2.152.252 |
| AMERIPRISE FINANCIAL INC | 122.164 | 1.915.532 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| STATE STREET CORP | 2.107.480 | 1.260.707 | +148.9 % | 33.045.286 |
| AMERICAN CENTURY COMPANIES INC | 1.329.619 | 736.225 | +124.1 % | 20.848.426 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.118.904 | 481.844 | +10.4 % | 80.265 |
| BlackRock, Inc. | 4.181.161 | 366.028 | +9.6 % | 65.560.605 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.029.066 | 334.124 | +48.1 % | 16.135.755 |
| Invesco Ltd. | 362.213 | 264.315 | +270.0 % | 5.679.500 |
| VANGUARD GROUP INC | 3.246.500 | 257.547 | +8.6 % | 50.905.120 |
| GOLDMAN SACHS GROUP INC | 295.878 | 194.734 | +192.5 % | 4.639.367 |
| Empowered Funds, LLC | 278.077 | 190.627 | +218.0 % | 4.360.247 |
| Nuveen, LLC | 285.859 | 182.891 | +177.6 % | 4.482.269 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BVF INC/IL | 3.835.886 | -1.824.246 | -32.2 % | 60.146.692 |
| FMR LLC | 1.300.096 | -1.512.155 | -53.8 % | 20.385.505 |
| Versant Venture Management, LLC | 4.382.687 | -1.270.235 | -22.5 % | 68.720.532 |
| Alphabet Inc. | 744.948 | -719.067 | -49.1 % | 11.680.785 |
| BAKER BROS. ADVISORS LP | 4.345.736 | -570.359 | -11.6 % | 68.141.140 |
| MARSHALL WACE, LLP | 398.890 | -503.944 | -55.8 % | 6.254.596 |
| ROYAL BANK OF CANADA | 2.818 | -432.949 | -99.4 % | 44.000 |
| MILLENNIUM MANAGEMENT LLC | 103.972 | -340.967 | -76.6 % | 1.630.281 |
| JANE STREET GROUP, LLC | 217.149 | -186.600 | -46.2 % | 3.404.897 |
| TWO SIGMA INVESTMENTS, LP | 14.000 | -147.481 | -91.3 % | 219.520 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | TCG Crossover GP III, LLC | Passiv (13G/A) | 2,70 % | 2.311.075 | -0,90 pp | |
| 15.05.2026 | TCG Crossover Fund III, L.P. | Passiv (13G/A) | 2,70 % | 2.311.075 | -0,90 pp | |
| 15.05.2026 | Chen Yu | Passiv (13G/A) | 5,50 % | 4.622.151 | -1,70 pp | |
| 15.05.2026 | TCG Crossover GP II, LLC | Passiv (13G/A) | 2,70 % | 2.311.076 | -0,90 pp | |
| 15.05.2026 | TCG Crossover Fund II, L.P. | Passiv (13G/A) | 2,70 % | 2.311.076 | -0,90 pp | |
| 15.05.2026 | Baker Bros. Advisors LP | Passiv (13G/A) | 9,99 % | 8.876.346 | +3,29 pp | |
| 15.05.2026 | Baker Bros. Advisors (GP) LLC | Passiv (13G/A) | 9,99 % | 8.876.346 | +3,29 pp | |
| 15.05.2026 | Julian C. Baker | Passiv (13G/A) | 9,99 % | 8.876.346 | +3,29 pp | |
| 15.05.2026 | Felix J. Baker | Passiv (13G/A) | 9,99 % | 8.876.346 | +3,29 pp | |
| 15.05.2026 | BVF PARTNERS L P/IL | Passiv (13G/A) | 6,30 % | 5.085.886 | +0,40 pp | |
| 15.05.2026 | BVF I GP LLC | Passiv (13G/A) | 3,40 % | 2.716.569 | +0,30 pp | |
| 15.05.2026 | BIOTECHNOLOGY VALUE FUND L P | Passiv (13G/A) | 3,40 % | 2.716.569 | +0,30 pp | |
| 15.05.2026 | BVF Partners OS Ltd. | Passiv (13G/A) | 0,40 % | 306.361 | 0,00 pp | |
| 15.05.2026 | BVF GP HOLDINGS LLC | Passiv (13G/A) | 5,80 % | 4.703.553 | +0,40 pp | |
| 15.05.2026 | LAMPERT MARK N | Passiv (13G/A) | 6,30 % | 5.085.886 | +0,40 pp | |
| 15.05.2026 | BIOTECHNOLOGY VALUE FUND II LP | Passiv (13G/A) | 2,50 % | 1.986.984 | +0,20 pp | |
| 15.05.2026 | Biotechnology Value Trading Fund OS LP | Passiv (13G/A) | 0,40 % | 306.361 | 0,00 pp | |
| 15.05.2026 | BVF II GP LLC | Passiv (13G/A) | 2,50 % | 1.986.984 | +0,20 pp | |
| 15.05.2026 | BVF INC/IL | Passiv (13G/A) | 6,30 % | 5.085.886 | +0,40 pp | |
| 22.04.2026 | Dimension Capital II GP, LLC | Passiv (13G/A) | 1,10 % | 850.500 | Neu | |
| 22.04.2026 | Dimension Management GP, LLC | Passiv (13G/A) | 8,10 % | 6.513.765 | -0,60 pp | |
| 22.04.2026 | Dimension Capital I GP, LLC | Passiv (13G/A) | 7,10 % | 5.663.265 | -1,60 pp | |
| 22.04.2026 | Dimension Management, L.P. | Passiv (13G/A) | 8,10 % | 6.513.765 | -0,60 pp | |
| 22.04.2026 | Adam Goulburn | Passiv (13G/A) | 8,10 % | 6.513.765 | -0,60 pp | |
| 22.04.2026 | Dimension Capital I, L.P. | Passiv (13G/A) | 7,10 % | 5.663.265 | -1,60 pp | |
| 22.04.2026 | Nan Li | Passiv (13G/A) | 8,10 % | 6.513.765 | -0,60 pp | |
| 22.04.2026 | Zavain Dar | Passiv (13G/A) | 8,10 % | 6.513.765 | -0,60 pp | |
| 22.04.2026 | Dimension Capital II, L.P. | Passiv (13G/A) | 1,10 % | 850.500 | Neu | |
| 19.03.2026 | Paul Walker | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Rick Yang | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Anthony A. Florence, Jr. | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Scott D. Sandell | Aktivist (13D/A) | 9,60 % | 7.692.298 | Neu | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | NEA Partners 17, L.P. | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Mohamad H. Makhzoumi | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Ali Behbahani | Aktivist (13D/A) | 9,70 % | 7.797.030 | -3,00 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Forest Baskett | Aktivist (13D/A) | 9,60 % | 7.692.298 | Neu | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | NEA 17 GP, LLC | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Carmen Chang | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | Edward T. Mathers | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 19.03.2026 | New Enterprise Associates 17, L.P. | Aktivist (13D/A) | 9,60 % | 7.692.298 | -2,90 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
Stammdaten
Monte Rosa Therapeutics, Inc., ein biopharmazeutisches Unternehmen, befasst sich mit der Entwicklung neuartiger Arzneimittel mit kleinen Molekülen, die die natürlichen Mechanismen des Körpers nutzen, um therapeutisch relevante Proteine selektiv abzubauen. Das Unternehmen entwickelt einen oralen Molecular-Glue-Degrader für GSPT1, einen Translationsterminations-Faktor und Degron-haltiges Protein zur Behandlung von Myc-getriebenen Krebsarten. Das Unternehmen entwickelt auch CDK2 zur Behandlung von Eierstock-, Gebärmutter- und Brustkrebs; NEK7 zur Behandlung von Entzündungskrankheiten wie Morbus Crohn, neurodegenerative Erkrankungen, Diabetes und Lebererkrankungen; VAV1, ein Zielprotein für Autoimmunerkrankungen; und BCL11A, ein therapeutisch relevantes Protein bei Hämoglobinopathien. Monte Rosa Therapeutics, Inc. wurde 2019 gegründet und hat seinen Hauptsitz in Boston, Massachusetts.
Unternehmen & Branche
| Name | Monte Rosa Therapeutics, Inc. |
|---|---|
| Ticker | GLUE |
| CIK | 0001826457 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 61225M102 |
|---|---|
| ISIN | US61225M1027 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,12 Mrd. USD |
| Beta | 1,59 |
Bewertung
| KBV (P/B) | 4,81 vs. 2,73 (2021) ▲ |
|---|---|
| FCF-Rendite | -2,5 % vs. -7,3 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -14,2 % vs. -21,3 % (2021) ▲ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 2,73 | 1,38 | 1,58 | 1,91 | 4,41 | |
| FCF-Rendite | -7,3 % | -28,1 % | -22,2 % | 8,9 % | -2,7 % | |
| Qualität & Bilanz | ||||||
| ROIC | -21,3 % | -34,1 % | -60,1 % | -27,4 % | -14,2 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -44.503.000 | 736.428.000 | 521.916.000 | ||
| 2025-12-31 | 10-K | -38.626.000 | 448.659.000 | 233.056.000 | ||
| 2025-09-30 | 10-Q | -27.081.000 | 459.841.000 | 245.837.000 | ||
| 2025-06-30 | 10-Q | -12.295.000 | 359.586.000 | 268.080.000 | ||
| 2025-03-31 | 10-Q | 46.885.000 | 393.199.000 | 275.160.000 | ||
| 2024-12-31 | 10-K | -72.700.000 | 438.732.000 | 222.936.000 | ||
| 2024-09-30 | 10-Q | -23.859.000 | 315.080.000 | 205.457.000 | ||
| 2024-06-30 | 10-Q | -30.310.000 | 344.114.000 | 224.671.000 | ||
| 2024-03-31 | 10-Q | -31.968.000 | 266.746.000 | 152.519.000 | ||
| 2023-12-31 | 10-K | -135.352.000 | 303.755.000 | 179.250.000 | ||
| 2023-09-30 | 10-Q | -34.884.000 | 252.103.000 | 184.524.000 | ||
| 2023-06-30 | 10-Q | -35.178.000 | 278.616.000 | 213.654.000 | ||
| 2023-03-31 | 10-Q | -32.038.000 | 309.028.000 | 243.726.000 | ||
| 2022-12-31 | 10-K | -108.501.000 | 342.389.000 | 271.413.000 | ||
| 2022-09-30 | 10-Q | -27.318.000 | 357.603.000 | 291.092.000 | ||
| 2022-06-30 | 10-Q | -26.469.000 | 365.056.000 | 302.050.000 | ||
| 2022-03-31 | 10-Q | -23.932.000 | 346.005.000 | 325.875.000 | ||
| 2021-12-31 | 10-K | -73.958.000 | 366.329.000 | 347.515.000 | ||
| 2021-09-30 | 10-Q | -19.837.000 | 384.049.000 | 369.305.000 | ||
| 2021-06-30 | 10-Q | -18.405.000 | 368.941.000 | 356.678.000 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 17.03.2026 | 10-K | 31.12.2025 | 76 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 20.03.2025 | 10-K | 31.12.2024 | 79 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 14.03.2024 | 10-K | 31.12.2023 | 74 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 16.03.2023 | 10-K | 31.12.2022 | 75 Tage | SEC » |
| 10.11.2022 | 10-Q | 30.09.2022 | 41 Tage | SEC » |
| 11.08.2022 | 10-Q | 30.06.2022 | 42 Tage | SEC » |
| 11.05.2022 | 10-Q | 31.03.2022 | 41 Tage | SEC » |
| 29.03.2022 | 10-K | 31.12.2021 | 88 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 12.08.2021 | 10-Q | 30.06.2021 | 43 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 02.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 26.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 23.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-08 | 17.415 | 19,81 | 344.991 |
| 2026-05-04 | 3.111 | 18,80 | 58.487 |
| 2026-04-20 | 6.718 | 19,78 | 132.882 |
| 2026-04-15 | 99 | 17,50 | 1.733 |
| 2026-04-13 | 4 | 17,48 | 70 |
| 2026-04-02 | 591 | 17,17 | 10.147 |
| 2026-03-26 | 5.154 | 15,71 | 80.969 |
| 2026-03-23 | 7.445 | 15,63 | 116.365 |
| 2026-03-17 | 1.296 | 16,35 | 21.190 |
| 2026-02-18 | 1.143 | 18,36 | 20.985 |
| 2026-01-20 | 49.301 | 23,71 | 1.168.927 |
| 2026-01-16 | 7.693 | 24,08 | 185.247 |
| 2026-01-15 | 7.493 | 24,06 | 180.282 |
| 2026-01-14 | 7.493 | 23,99 | 179.757 |
| 2026-01-13 | 7.452 | 23,72 | 176.761 |
| 2026-01-08 | 287 | 23,28 | 6.681 |
| 2026-01-07 | 24.164 | 16,01 | 386.866 |
| 2026-01-05 | 1.791 | 15,31 | 27.420 |
| 2025-12-31 | 4.061 | 15,97 | 64.854 |
| 2025-12-30 | 37 | 16,12 | 596 |
| 2025-12-29 | 14.675 | 17,29 | 253.731 |
| 2025-12-26 | 6.891 | 17,64 | 121.557 |
| 2025-12-22 | 47.012 | 15,54 | 730.566 |
| 2025-12-18 | 47.428 | 16,75 | 794.419 |